With SC14 kicking off today, it’s timely to look at how high performance computing (HPC) is impacting today’s valuable life sciences research. In the above podcast, Dr. Rudy Tanzi, the Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard Medical School and the Director, Genetics and Aging Research Unit at the MassGeneral Institute for Neurodegenerative Disease, talks about his pioneering research in Alzheimer’s disease and how HPC is critical to the path forward.
Listen to the conversation and hear how Dr. Tanzi says HPC still has a ways to go to provide the compute power that life sciences researchers need. What do you think?
What questions about HPC do you have?
If you’re at SC14, remember to come by the Intel booth (#1315) for life sciences presentations in the Intel Community Hub and Intel Theater. See the schedules here.